Free Trial

National Health Investors (NYSE:NHI) Share Price Crosses Above Fifty Day Moving Average - Here's Why

National Health Investors logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • National Health Investors shares moved above their 50-day moving average, trading as high as $68.82 and last changing hands near $68.48. The stock remains below its 200-day moving average of $76.37.
  • Analyst sentiment is generally favorable, with five Buy ratings and four Holds producing a “Moderate Buy” consensus and an average price target of $81.00.
  • NHI declared a quarterly dividend of $0.92, equivalent to $3.68 annually and a 5.4% yield. Institutional investors own 62.51% of the company, while the REIT reported $1.19 in quarterly EPS and $121.32 million in revenue.
  • MarketBeat previews top five stocks to own in December.

Shares of National Health Investors, Inc. (NYSE:NHI - Get Free Report) crossed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $68.00 and traded as high as $68.82. National Health Investors shares last traded at $68.4810, with a volume of 296,266 shares traded.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Zacks Research upgraded National Health Investors from a "strong sell" rating to a "hold" rating in a research note on Tuesday, September 29th. Truist Financial cut their price objective on National Health Investors from $81.00 to $80.00 and set a "buy" rating on the stock in a research note on Wednesday, September 2nd. BMO Capital Markets reaffirmed an "outperform" rating on shares of National Health Investors in a report on Wednesday, September 23rd. Weiss Ratings lowered National Health Investors from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Friday, September 25th. Finally, National Bank Financial set a $79.00 target price on National Health Investors in a research report on Wednesday, September 9th. Five investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $81.00.

View Our Latest Stock Report on NHI

National Health Investors Trading Up 2.1%

The firm has a market cap of $3.36 billion, a P/E ratio of 19.79, a P/E/G ratio of 4.18 and a beta of 0.49. The business's 50-day moving average is $68.00 and its two-hundred day moving average is $76.37. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81.

National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm had revenue of $121.32 million for the quarter. During the same period in the prior year, the business earned $1.22 EPS. The business's revenue was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, analysts expect that National Health Investors, Inc. will post 4.76 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 annualized dividend and a dividend yield of 5.4%. National Health Investors's dividend payout ratio (DPR) is 108.67%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new stake in shares of National Health Investors in the second quarter valued at approximately $665,997,000. Bank of New York Mellon Corp acquired a new position in shares of National Health Investors during the second quarter worth approximately $122,509,000. Bank of America Corp DE acquired a new position in shares of National Health Investors during the second quarter worth approximately $77,738,000. Legal & General Group Plc acquired a new position in shares of National Health Investors during the second quarter worth approximately $21,745,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its holdings in National Health Investors by 374.8% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 239,542 shares of the real estate investment trust's stock worth $15,721,000 after buying an additional 189,096 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company's stock.

About National Health Investors

(Get Free Report)

National Health Investors, Inc NYSE: NHI is a real estate investment trust that owns and finances income-producing healthcare real estate in the United States. The company primarily focuses on properties serving older adults and patients who require specialized care.

NHI's portfolio includes independent living communities, assisted living and memory care facilities, skilled nursing facilities, continuing care retirement communities, medical office buildings and other healthcare-related properties.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines